Literature DB >> 19909458

How useful is traditional herbal medicine for pulmonary fibrosis?

Jiao Yang1, Ye Cui, Martin Kolb.   

Abstract

IPF, despite considerable advances in clinical management and understanding of its complex pathophysiology, is still a fatal disease without effective treatment. Herbal medicine has been used for more than 5000 years and is the central component of medical practice in many parts of Asia. Not surprisingly, traditional and herbal medicine is also widely applied for treatment of IPF. This review describes the most important herbal medicines that are used for IPF treatment. The relevant experimental studies investigating potential mechanisms of these drugs are discussed. The best conducted clinical studies which have reported beneficial effects of some herbal medications in the management of IPF are also evaluated. Overall, there is considerable experimental support from preclinical studies for some of these herbal medicines, but the translation into clinical practice appears difficult. The clinical trials evaluating their anti-fibrotic potential are not fulfilling the standards expected from 'Western' medicines. Systematic clinical research in this field is still in its infancy, and as such, the routine use of traditional and herbal medicine cannot be recommended for patients suffering from IPF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19909458     DOI: 10.1111/j.1440-1843.2009.01644.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  6 in total

Review 1.  Chinese Herbal Medicines Compared with N-Acetylcysteine for the Treatment of Idiopathic Pulmonary Fibrosis: A Systematic Review of Randomized Controlled Trials.

Authors:  Jing Guo; Bin Li; Wenbin Wu; Zhichao Wang; Fei Wang; Taipin Guo
Journal:  Evid Based Complement Alternat Med       Date:  2019-06-13       Impact factor: 2.629

Review 2.  Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects.

Authors:  Liu-Cheng Li; Lian-Di Kan
Journal:  J Ethnopharmacol       Date:  2016-12-28       Impact factor: 4.360

3.  Sodium Houttuyfonate Inhibits Bleomycin Induced Pulmonary Fibrosis in Mice.

Authors:  Yun-Hui Shen; Ming-Han Cheng; Xin-Yu Liu; De-Wei Zhu; Jian Gao
Journal:  Front Pharmacol       Date:  2021-02-25       Impact factor: 5.810

Review 4.  Drugs and Targets in Fibrosis.

Authors:  Xiaoyi Li; Lixin Zhu; Beibei Wang; Meifei Yuan; Ruixin Zhu
Journal:  Front Pharmacol       Date:  2017-11-23       Impact factor: 5.810

5.  Chinese herbal medicines compared with N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: Protocol for a systematic review.

Authors:  Jing Guo; Bin Li; Wenyuan Li; Yi Pan; Zhichao Wang; Yuxiao Wu; Fei Wang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

6.  The Influence of BuqiHuoxueTongluo Formula on Histopathology and Pulmonary Function Test in Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rats.

Authors:  Xiaolin Yu; Yanxia Zhang; Xiaohua Yang; Xiaomei Zhang; Xinxiang Wang; Xuemei Liu; Yan Yan
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-26       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.